Ibuprofen Banner

Ibuprofen, the active ingredient in Ibuprofen Banner, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain, fever, and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofen Banner as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, and musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory conditions. - Inflammation: reduces swelling in conditions such as arthritis or minor injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or heartburn. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild rash or itching. - Elevated blood pressure in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic injury or elevated liver enzymes. - Increased risk of cardiovascular events such as myocardial infarction.

Before initiating therapy, consider the following safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: avoid in patients with severe kidney disease. - Evaluate cardiovascular status: use the lowest effective dose for the shortest duration. - Check for hypersensitivity: discontinue if rash, swelling, or breathing difficulty occurs. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Ibuprofen can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Lithium: ibuprofen may raise serum lithium concentrations. - Methotrexate: reduced clearance can lead to toxicity.